Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

ERYTHROMYCIN

ERYTHROMYCIN

Standard Dose
2%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 090215 (ANDA).

Marketing status: Prescription Active ingredient ERYTHROMYCIN Form and strength SWAB;TOPICAL - 2% Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2010-05-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 090215 (ANDA). Marketing status: Prescription Active ingredient ERYTHROMYCIN Form and strength SWAB;TOPICAL - 2% Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2010-05-12 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.